How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 101, Issue 1, 2002, Pages 6-14

  Alfirevic, Zarko ^a   Roberts, Devender ^a   Martlew, Vanessa ^b  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Intrauterine growth restriction; Placental abruption; Pre eclampsia; Stillbirth; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; DISEASE ASSOCIATION; ECLAMPSIA; GENE MUTATION; GENETIC HETEROGENEITY; HOMOCYSTINURIA; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SCREENING; SOLUTIO PLACENTAE; STILLBIRTH; THROMBOPHILIA;

EID: 0037050786     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00496-1     Document Type: Review

References (31)

1. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss
2. EPCOT study: Increased fetal loss in women with heritable thrombophilia
3. Case-control study of the frequency of thrombophilic disorders in couples with late fetal loss and no thrombotic antecedent
4. Increased frequency of genetic thrombophilia in women with complications of pregnancy
5. Changes in homocysteine levels during normal pregnancy
6. APC resistance and other haemostatic variables during pregnancy and puerperium
7. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies
8. Hyperhomocysteinemia: A risk factor for placental abruption or infarction
9. Resistance to activated protein C and the Leiden mutation: High prevalence in patients with abruptio placentae
10. The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae
11. High prevalence of activated protein C resistance due to factor V Leiden mutation in cases of intrauterine death
12. Relationship between pregnancy loss and antiphospholipid antibody
13. 6 supplementation on women with hyperhomocysteinemia and a history of pre-eclampsia or fetal growth restriction
14. 5,10-Metheylenetetrahydrofolate reductase polymorphism in black South African women pre-eclampsia
15. Underlying disorders associated with severe early-onset pre-eclampsia
16. The factor V Leiden mutation may predispose women to severe pre-eclampsia
17. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria
18. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan
19. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome
20. Pre-eclampsia is associated with a reduced response to activated protein C
21. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women
22. Factor V Leiden and thermo-labile methylenetetrahydrofolate reductase gene variants in an East Anglian pre-eclampsia cohort
23. High prevalence of hemostatic abnormalities in women with severe pre-eclampsia
24. Activated protein C resistance shows an association with pregnancy-induced hypertension
25. Pre-eclampsia and genetic risk factors for thrombosis: A case-control study
26. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies
27. Methylenetetrahydrofolate reductase polymorphism, folate and susceptibility to pre-eclampsia
28. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia
29. Hemostatic abnormalities may predict chronic hypertension after pre-eclampsia
30. Ethnic and racial factors in cobalamin metabolism and its disorders